March 2012- Central Nervous System

The wider range of symptoms found in Asperger's syndrome makes the disorder a challenge to diagnose and treat.

The FDA approved a new formulation of immediate-release oxycodone. Oxecta (oxycodone HCI), for the treatment of acute and chronic moderate to severe pain.

Patients need education about the potential pitfalls of taking herbal supplements.

When a recalled medication causes the death of a patient, a grieving family files suit against the pharmacy.

MedGuard Safes can help patients ensure that needed medications, especially controlled substances, remain in the right hands.

Vestibular disruptions from medications or central nervous system disorders can cause this unsettling sensation.

Ensuring patient access to community pharmacists is going to be an important part of health care reform.

Abbreviations used for dosing and drug names can lead to dispensing mistakes.

Patients with schizophrenia and other disorders who take atypical antipsychotics should be monitored for an increased risk for diabetes.

Hand sanitizing products are everywhere, but are they effective for infection control?

Some common ear problems can be addressed with OTC or pharmacologic interventions.